Oruka Therapeutics, Inc. (ORKA)
Across 54 earnings reports since Feb 15, 2005, Oruka Therapeutics, Inc. (ORKA) has a clear post-earnings pattern. It moves ±3.16% on average after reporting and finishes higher 44.4% of the time. Its largest post-earnings gain was +9.23% (May 05, 2006) and its largest decline was -19.4% (Nov 14, 2018). The next earnings report is predicted for 2026-09-18 (estimated).
Earnings reactions
How ORKA moved on each past earnings report.
Earnings Impact
Total Earnings
54
Avg Abs. Movement
±3.16%
Positive %
44.4%
Negative %
55.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Apr 30, 2026 | ☽ POST | -8.58% | open_in_new |
| Sep 05, 2024 | ☽ POST | +2.8% | open_in_new |
| Apr 25, 2024 | ☽ POST | +2.87% | open_in_new |
| Feb 01, 2024 | ☽ POST | +2.53% | open_in_new |
Earnings Count
54
Total earnings in dataset
Avg Abs. Movement
±3.16%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260715 | open_in_new SEC.gov |
| 4 | 20260715 | open_in_new SEC.gov |
| 144 | 20260713 | open_in_new SEC.gov |
| 4 | 20260713 | open_in_new SEC.gov |
| 144 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260701 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
Frequently asked about ORKA earnings
When does Oruka Therapeutics, Inc. report earnings next? expand_more
Oruka Therapeutics, Inc. (ORKA)'s next earnings date is estimated for 2026-09-18. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ORKA stock move after earnings? expand_more
Over 54 reports, ORKA has moved an average of ±3.16% the session after earnings, closing higher 44.4% of the time.
What was ORKA's biggest post-earnings move? expand_more
ORKA's largest post-earnings gain on record was +9.23% on May 05, 2006, and its largest decline was -19.4% on Nov 14, 2018.
Where can I find Oruka Therapeutics, Inc.'s SEC filings? expand_more
All of Oruka Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right